Leblond Chain J - Search Results

1

Poly(N-methyl-N-vinylacetamide): A Strong Alternative to PEG for Lipid-Based Nanocarriers Delivering siRNA.

Berger M, Toussaint F, Ben Djemaa S, Maquoi E, Pendeville H, Evrard B, Jerôme C, Leblond Chain J, Lechanteur A, Mottet D, Debuigne A, Piel G. Berger M, et al. Among authors: leblond chain j. Adv Healthc Mater. 2024 Mar;13(8):e2302712. doi: 10.1002/adhm.202302712. Epub 2023 Nov 30. Adv Healthc Mater. 2024. PMID: 37994483

2

Purification processes of polymeric nanoparticles: How to improve their clinical translation?

Tehrani SF, Bharadwaj P, Leblond Chain J, Roullin VG. Tehrani SF, et al. Among authors: leblond chain j. J Control Release. 2023 Aug;360:591-612. doi: 10.1016/j.jconrel.2023.06.038. Epub 2023 Jul 15. J Control Release. 2023. PMID: 37422123 Review.

3

Effect of PEG Anchor and Serum on Lipid Nanoparticles: Development of a Nanoparticles Tracking Method.

Berger M, Degey M, Leblond Chain J, Maquoi E, Evrard B, Lechanteur A, Piel G. Berger M, et al. Among authors: leblond chain j. Pharmaceutics. 2023 Feb 10;15(2):597. doi: 10.3390/pharmaceutics15020597. Pharmaceutics. 2023. PMID: 36839919 Free PMC article.

4

Switchable Lipids: From Conformational Switch to Macroscopic Changes in Lipid Vesicles.

Phan HT, Passos Gibson V, Guédin A, Ibarboure E, El Mammeri N, Grélard A, Le Meins JF, Dufourc EJ, Loquet A, Giasson S, Leblond Chain J. Phan HT, et al. Among authors: leblond chain j. Langmuir. 2023 Feb 28;39(8):3072-3082. doi: 10.1021/acs.langmuir.2c03149. Epub 2023 Feb 15. Langmuir. 2023. PMID: 36793207

5

Bimodal brush-functionalized nanoparticles selective to receptor surface density.

Phan HT, Lauzon D, Vallée-Bélisle A, Angioletti-Uberti S, Leblond Chain J, Giasson S. Phan HT, et al. Among authors: leblond chain j. Proc Natl Acad Sci U S A. 2023 Jan 17;120(3):e2208377120. doi: 10.1073/pnas.2208377120. Epub 2023 Jan 11. Proc Natl Acad Sci U S A. 2023. PMID: 36630450 Free PMC article.

6

WITHDRAWN: Aptamer-based nanotrains and nanoflowers as quinine delivery systems.

Cao M, Vial A, Minder L, Guédin A, Fribourg S, Azéma L, Feuillie C, Molinari M, Di Primo C, Barthélémy P, Leblond Chain J. Cao M, et al. Among authors: leblond chain j. Int J Pharm. 2023 Feb 5;632:122552. doi: 10.1016/j.ijpharm.2022.122552. Epub 2022 Dec 29. Int J Pharm. 2023. PMID: 36587777

7

Programmable self-regulated molecular buffers for precise sustained drug delivery.

Desrosiers A, Derbali RM, Hassine S, Berdugo J, Long V, Lauzon D, De Guire V, Fiset C, DesGroseillers L, Leblond Chain J, Vallée-Bélisle A. Desrosiers A, et al. Among authors: leblond chain j. Nat Commun. 2022 Nov 2;13(1):6504. doi: 10.1038/s41467-022-33491-7. Nat Commun. 2022. PMID: 36323663 Free PMC article.

8

Lipid Coating of Chitosan Nanogels for Improved Colloidal Stability and In Vitro Biocompatibility.

Passos Gibson V, Nunes JBB, Falcao DQ, Roullin VG, Leblond Chain J. Passos Gibson V, et al. Among authors: leblond chain j. AAPS PharmSciTech. 2021 May 21;22(5):159. doi: 10.1208/s12249-021-02027-5. AAPS PharmSciTech. 2021. PMID: 34019243

9

Switchable Lipid Provides pH-Sensitive Properties to Lipid and Hybrid Polymer/Lipid Membranes.

Passos Gibson V, Fauquignon M, Ibarboure E, Leblond Chain J, Le Meins JF. Passos Gibson V, et al. Among authors: leblond chain j. Polymers (Basel). 2020 Mar 11;12(3):637. doi: 10.3390/polym12030637. Polymers (Basel). 2020. PMID: 32168824 Free PMC article.

10

GM1-Binding Conjugates To Improve Intestinal Permeability.

Melkoumov A, St-Jean I, Banquy X, Leclair G, Leblond Chain J. Melkoumov A, et al. Among authors: leblond chain j. Mol Pharm. 2019 Jan 7;16(1):60-70. doi: 10.1021/acs.molpharmaceut.8b00776. Epub 2018 Nov 29. Mol Pharm. 2019. PMID: 30422668

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page